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Abstract
Dengue is one of the most important arboviral diseases caused by infection of four serotypes of dengue virus (DEN). We
found that activation of interferon regulatory factor 3 (IRF3) triggered by viral infection and by foreign DNA and RNA
stimulation was blocked by DEN-encoded NS2B3 through a protease-dependent mechanism. The key adaptor protein in
type I interferon pathway, human mediator of IRF3 activation (MITA) but not the murine homologue MPYS, was cleaved in
cells infected with DEN-1 or DEN-2 and with expression of the enzymatically active protease NS2B3. The cleavage site of
MITA was mapped to LRRQ
96G and the function of MITA was suppressed by dengue protease. DEN replication was reduced
with overexpression of MPYS but not with MITA, while DEN replication was enhanced by MPYS knockdown, indicating an
antiviral role of MITA/MPYS against DEN infection. The involvement of MITA in DEN-triggered innate immune response was
evidenced by reduction of IRF3 activation and IFN induction in cells with MITA knockdown upon DEN-2 infection. NS2B3
physically interacted with MITA, and the interaction and cleavage of MITA could be further enhanced by poly(dA:dT)
stimulation. Thus, we identified MITA as a novel host target of DEN protease and provide the molecular mechanism of how
DEN subverts the host innate immunity.
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Introduction
Dengue has emerged as a rapidly spreading vector-borne
disease annually affecting 50 to 100 million people living in
tropical and subtropical areas [1,2]. Dengue virus (DEN) infection
of humans causes a spectrum of illnesses ranging from mild
classical dengue fever to severe dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS). The pathogenesis of severe
dengue diseases remains unclear, but magnitude of DEN
replication is believed to be one of the major determining factors
[3]. Type I interferons (IFNs), mainly IFNa and IFNb, play central
roles in host defense against viral infection [4,5]. DEN replication
was sensitive to IFN in both cell-based assays and infected animals
[6,7], and the IFN-induced 29,59-oligoadenylate synthetase
(OAS)/RNase L pathway may contribute to host defense against
DEN infection [8–10]. Thus, for DEN to survive and replicate in
host cells, it likely needed to evolve a way to downregulate the
cellular IFN system.
DEN triggers IFNb through a molecular mechanism involving
the retinoic acid inducible gene I (RIG-I) signaling pathway
[11,12]. RIG-I binding to viral RNA triggers conformational
changes that expose the N-terminal caspase recruitment domain
(CARD) [13]. Mitochondrial antiviral signaling (MAVS) [14,15],
also called VISA [16], IPS-1 [17], and Cardif [18], relays the
signal to activate the downstream kinases, thus resulting in
activation of IFN regulatory factor 3 (IRF3), IRF7, and NF-kB,
and finally IFN production [13,19]. DEN is known to be a weak
IFN inducer [11,20] and MAVS is cleaved by caspases in DEN-
infected cells [21]. Furthermore, IFN induction in response to
poly(I:C) transfection and infection by several viruses such as
Newcastle disease virus, Sendai virus (SeV), and Semliki Forest
virus was reduced in DEN-infected human dendritic cells [22]. A
catalytically active DEN NS2B3 protease was found to reduce the
IFNb promoter activation triggered by SeV infection and poly(I:C)
transfection [22]. However, the molecular target of dengue
protease in IFN induction remains elusive.
Mediator of IRF3 activation (MITA) [23], also known as
stimulator of interferon genes (STING) [24], endoplasmic
reticulum IFN stimulator (ERIS) [25], and transmembrane protein
173 (TMEM173), shares 81% similarity (68% identity) with its
murine homologue MPYS [26]. MITA is a membrane protein
involved in IFN production triggered by viral RNA and dsDNA
[23–25]. MITA interacts with RIG-I, forms a complex with
MAVS, activates IRF3 phosphorylation, and is required for IFN
induction triggered by RNA and DNA viruses [23,24,27]. MITA
is positively and negatively regulated by multiple mechanisms.
Phosphorylation of MITA by TBK1 is critical for virus-induced
IRF3 activation [23]. K63-linked ubiquitination of MITA by
TRIM56 induces MITA dimerization, and then recruits TBK1 for
subsequent IFN induction [28]. MITA is downregulated by
RNF5, an E3 ubiquitin ligase, which targets MITA for
ubiquitination and degradation [29]. MITA association with
PLoS Pathogens | www.plospathogens.org 1 June 2012 | Volume 8 | Issue 6 | e1002780TBK1 with dsDNA stimulation was downregulated by Atg9a, an
autophagy related protein [30]. Interestingly, amino acids 125–
222 of MITA exhibit homology to flaviviral NS4B proteins, and
yellow fever virus NS4B has been shown to suppress MITA-
mediated IFN production [27].
To understand the molecular target of dengue protease in IFN
pathway, we investigated the cleavage of MITA and MPYS in cells
infected with DEN or with expression of DEN protease. MITA,
but not murine homologue MPYS, was cleaved in a DEN
protease-dependent manner, which led to impaired IRF3 activa-
tion stimulated by Japanese encephalitis virus (JEV) infection or by
transfection with poly(I:C) or poly(dA:dT). The potential cleavage
site on MITA was mapped and the possible regulatory mecha-
nisms and biological significance of torpid MITA signaling by
dengue protease are discussed.
Results
Dengue NS2B3 suppresses virus-, dsRNA-, and dsDNA-
induced IRF3 activation
DEN antagonizes type I IFN response in human dendritic cells
through a catalytically active protease complex, NS2B3 [22]. To
further address the role of dengue protease in suppressing the IFN
pathway, we established a stable DEN-2 protease NS2B3-
overexpressing A549 cell line by lentiviral transduction. A single
point mutation changing serine residue 135 of NS3 to alanine
(S135A) abolished protease activity, as evidenced by loss of NS2B3
autocleavage (Figure 1C and 1D). JEV, known to induce high level
of IRF3 activation and trigger IFN induction [11], whose
replication was not affected by dengue protease (Figure S2) was
used as a viral IFN inducer in this study. In contrast to control cells
overexpressing GFP, cells overexpressing dengue NS2B3 showed
reduced phosphorylation of IRF3 triggered by JEV infection
(Figure S1). JEV-induced IRF3 nucleus translocation (Figure 1A,
1B and Table S1), dimerization (Figure 1C), and phosphorylation
(Figure 1C), were all reduced in cells overexpressing the wild-type
but not enzyme-dead (S135A) NS2B3, under similar levels of JEV
replication (Figure S2).
To ascertain the spectrum of this inhibitory effect of dengue
protease, we transfected cells with poly(dA:dT) and poly(I:C), two
synthetic analogs of dsDNA and dsRNA, respectively, that mimic
foreign nucleic acids from pathogens. Cells overexpressing the
enzymatically active dengue NS2B3 showed attenuated IRF3
phosphorylation triggered by poly(dA:dT) or poly(I:C) transfection
(Figure 1D). Therefore, virus-, DNA- and RNA-triggered IRF3
activation could be subverted by dengue NS2B3 in a protease
activity-dependent manner.
MITA is the target of dengue protease NS2B3
To reveal the molecular target of dengue protease in the IFN
pathway, three key molecules in pattern recognition receptor
(PRR) signaling, RIG-I, MAVS, and MITA, were cotransfected
with the wild-type (WT) or S135A-mutated NS2B3. The protein
expression of RIG-I and MAVS appeared to be similar in cells
with WT or S135A-mutated NS2B3 overexpression (Figure 2A).
However, the protein bands corresponding to the full-length and
the dimer [25] form of MITA were reduced in cells cotransfected
with the wild-type but not S135A-mutated NS2B3, and an extra
protein band of smaller size was detected in NS2B3(WT)-
transfected cells (Figure 2A), indicating a cleavage of MITA in
dengue protease-overexpressing cells. This MITA-cleavage event
seems to be specific for dengue protease, because JEV protease,
which shares similar substrate sequences as DEN, did not cleave
MITA (Figure 2B). The cleavage of MITA could also be detected
in cells infected with DEN-2, PL046 and NGC-N strains or with
DEN-1 Hawaii strain but not with JEV (Figure 2C).
Importantly, this cleavage impaired the normal function of
MITA, because the viperin promoter-driven reporter, Vip-Luc,
with expression under the control of ISRE [31], was dose-
dependently downregulated by cotransfection with the wild-type
but not S135A-mutated dengue NS2B3 (Figure 2D). The MITA-
triggered activation of the IFNb promoter-driven reporter p125-
Luc (Figure S3) and the induction of endogenous IFNb mRNA
(Figure 2E) were also reduced by dengue protease. However, Vip-
Luc and p125-Luc triggered by TBK1, a downstream kinase of
IFN pathway [23,24], were not affected by dengue protease
(Figure S4).
Furthermore, culture medium derived from A549 cells trans-
fected with MITA plus S135A-mutated NS2B3 expression showed
a stronger anti-VSV status than that from MITA plus the wild-
type NS2B3 in Vero cells (Figure S5). We further used an IFN-
sensitive recombinant sindbis virus containing a Firefly luciferase
reporter gene (dSinF-Luc/2A) [32] to quantify the impact of DEN
antagonizing antiviral activity. As expected, the luciferase activities
derived from dSinF-Luc/2A were dose-dependently reduced by
IFNa treatment (Figure S6A). Furthermore, dSinF-Luc/2A
replicated to higher level in cells pre-infected with DEN-2 (Figure
S6B), supporting the notion that DEN-2 dampens IFN pathway.
Consistent with the VSV results (Figure S5), culture medium
derived from cells with transfection of MITA and S135A-mutated
NS2B3 expression showed a stronger antiviral activity against
dSinF-Luc/2A as compared to that from transfection of MITA
with wild-type NS2B3 expression (Figure 2F). Our results suggest
that DEN infection subverts the innate IFN immunity by cleaving
MITA through a dengue protease-dependent mechanism.
The residues 93–96 (LRRG) of MITA are important for
dengue protease cleavage
To determine the potential cleavage site of dengue protease in
MITA, we added an HA-tag and a V5-tag to the N and C termini,
respectively, of MITA (Figure 3A). Western blot analysis with
antibodies against the tags showed that the N- and C-terminal
Author Summary
The pathogenesis of severe dengue diseases remains
unclear, but magnitude of dengue virus (DEN) replication
is believed to be one of the major determining factors.
Thus, revealing how DEN evades the host defense
mechanism such as type I interferon (IFN) system is
important for better understanding this devastating
disease. Although several DEN viral proteins have been
reported as IFN-resistant factors, without knowing the
cellular targets, the mechanism of how DEN subverts IFN
system is poorly understood. In this study, we found that
the human mediator of IRF3 activation (MITA), also known
as STING and ERIS, was cleaved in cells infected with DEN
and in cells expressing an enzymatically active DEN
protease NS2B3. MITA is known as a DNA sensor for IFN
production and its antiviral role has also been demon-
strated for several DNA and RNA viruses. DEN protease
appears to cleave MITA but not its murine homologue
MPYS, and this cleavage resulted in impaired MITA
activation. Ectopic overexpression of MPYS but not MITA
reduced DEN replication, and knockdown of endogenous
MPYS enhanced DEN replication. Thus, we find that MITA/
MPYS is involved in host defense against DEN replication
and DEN protease targets MITA to subvert its antiviral
effect.
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,1/4 (,12 kDa) and ,3/4 (,35 kDa) of the full-length MITA
(379 amino acids, ,47 kDa with tags), respectively (Figure 3B).
Because the consensus cleavage sites for dengue proteases are two
basic residues followed by a small amino acid, we suspected
LRRQ
96G as the most likely cleavage site of MITA by dengue
NS2B3. We constructed plasmids expressing the expected cleavage
products: HA-MITA-N for the N-terminal residues 1–95 plus an
HA tag and MITA-C-V5 for the C-terminal residues 96–379 plus
a V5 tag. The smaller fragments of MITA produced by NS2B3
cotransfection co-migrated with HA-MITA-N (a.a. 1–95) and
MITA-C-V5 (a.a. 96–379) (Figure 3B), suggesting that
LRRQ
96G, located between the second and the third transmem-
brane domain of MITA, is likely the site cleaved by dengue
NS2B3. To understand the influence of this cleavage on MITA
function, we determined whether these truncated MITAs were still
Figure 1. Suppression of IRF3 activation by dengue NS2B3 depends on its protease activity. (A) A549 cells were stably transduced with
lentivirus expressing dengue NS2B3 (WT) or its protease-dead mutant S135A. Cells were mock infected or infected with JEV (multiplicity of infection
[MOI] 5) for 24 h, and then fixed for immunofluorescence assay (IFA). Green, viral proteins as indicated; red, endogenous IRF3. (B) The percentage of
IRF3 nucleus translocation were determined from three independent experiments and shown as the mean and SD. Data of the indicated groups were
compared by two-tailed Student’s t test. (C) IRF3 activation was analyzed by IRF3 dimerization with native PAGE (black arrow, dimer; open arrow,
monomer) and immunoblotting with antibodies against S396 phospho-IRF3 (pIRF3) and IRF3 by SDS-PAGE as indicated. Western blotting was also
performed with antibodies against JEV NS5, DEN/JEV NS3, GFP, and actin. (D) Western blot analysis of IRF3 and pIRF3 in stable cell lines expressing
the wild-type or S135A-mutated dengue NS2B3 transfected with poly(dA:dT) or poly(I:C) at the indicated dose. The band density was quantified with
ImageJ and the relative ratios of pIRF3 to IRF3 are shown in panels C and D. The western blot results are the representative data from three
independent experiments.
doi:10.1371/journal.ppat.1002780.g001
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Luc with the MITA deletion constructs revealed that neither
MITA-N nor MITA-C could trigger Vip-Luc expression as did the
full-length MITA (Figure 3C), so cleavage of MITA by dengue
protease would dampen its normal cellular function.
We further checked whether the murine homolog of MITA,
MPYS (Gene ID:72512) [23–26], is sensitive to dengue protease.
Different from the results for MITA, the expression pattern of
MPYS was not changed by cotransfection with dengue NS2B3
(Figure 3D). Furthermore, replacing the LRRG sequences of
MITA with the corresponding sequence IHCM found in MPYS
reduced the cleavage of MITA by dengue NS2B3 (Figure 3D),
which supports LRRQ
96G as the target site of dengue protease in
MITA. However, changing only one residue of the LRRG motif,
L93I, R94A, R95A and G96P mutation, did not confer resistance
to dengue protease of MITA (Figure S7). We also noted that some
Figure 2. MITA is targeted by dengue protease. (A) N-terminal Flag-tagged RIG-I, MITA, or MAVS was cotransfected with dengue NS2B3
(DNS2B3) in 293T/17 (lanes 1 and 2) or A549 (lanes 3–6) cells. Cells were harvested for western blotting at 18 h post transfection with the indicated
antibodies. Molecule weight (kDa) markers are shown on the sides. The position for full-length MITA is indicated by a black arrow and for the cleaved
MITA by an open arrow. (B) A549 cells were cotransfected with HA-MITA-V5 plus the viral protease encoded by JEV or DEN-2 (WT and S135A) and
analyzed by immunoblotting with antibodies against HA-tag and NS3. (C) A549 cells stably expressing HA-MITA-V5 were infected with the indicated
virus (MOI 5) for 24 h and then analyzed by immunoblotting with antibodies against HA-tag, NS3, and actin. (D) A549 cells were cotransfected with
HA-MITA-V5 (0.3 mg), Vip-Luc (0.15 mg), IRF3/pCR3.1 (0.15 mg), pRL-TK (0.05 mg), and different doses of WT or S135A-mutated dengue NS2B3 (0.3,
0.45, or 0.6 mg) for 24 h. GFP plasmid was used as transfection plasmid control. The cell lysates were harvested and analyzed by dual-luciferase assay.
Firefly luciferase activity was normalized to that of Renilla luciferase. The relative luciferase activity to that of cotransfection of GFP plus MITA was
calculated. Data are expressed as mean and SD (n=3per group), and were compared by two-tailed Student’s t test. (E) Quantification of endogenous
IFNb mRNA levels by RT-qPCR. The WT and S135A NS2B3-expressing A549 cells were transfected with MITA or GFP for 24 h and harvested for RT-
qPCR of IFNb and actin. Data are expressed as mean and SD (n=3per group), and were compared by two-tailed Student’s t test. (F) Vero cells were
pretreated with culture medium derived from NS2B3-expressing A549 cells transfected with MITA or GFP as indicated. The conditioned Vero cells
were infected with dSinF-Luc/2A (500 pfu/well) for 24 h and then harvested for luciferase assay. Data are expressed as mean and SD (n=3per group),
and were compared by two-tailed Student’s t test.
doi:10.1371/journal.ppat.1002780.g002
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greatly lost their ability to trigger Vip-Luc expression, suggesting
that this LRRG region is important for MITA’s function (Figure
S7). To test whether introducing the cleavage site LRRG from
MITA to MPYS would make MPYS susceptible to DEN protease,
we made a MPYS-LRRG construct by replacing the IHCM
sequences of MPYS with LRRG. MPYS-LRRG was still resistant
to the cleavage of DEN protease (Figure 3D).
To address the interplay of dengue protease with MITA versus
MPYS, we used immunoprecipitation-immunoblotting (IP-west-
ern) assay to determine whether these proteins physically interact
with each other. Cells were cotransfected with V5-tagged MITA
or MPYS plus the Flag-tagged enzyme-dead (S135A) dengue
protease. Immunoprecipitation of MITA with anti-V5 antibody
co-precipitated NS2B3 (Figure S8). DEN protease interacted with
MITA, and to a lesser extent also with MITA-IHCM-mutant, but
not much with WT and LRRG-mutant of MPYS (Figure S8).
Cotransfection of MITA with dengue NS2B3 suppressed more
than 50% of Vip-Luc activity as compared to transfection with the
enzyme-dead S135A mutant; while Vip-Luc triggered by the
dengue protease-resistant MPYS remained unaffected by NS2B3
cotransfection (Figure 3E). Therefore, dengue protease subverts
innate immunity by cleavage of human MITA.
MPYS but not MITA downregulates DEN replication
To determine whether the endogenous MITA is targeted by
DEN infection, we detected the protein levels of MITA and
several IFN signaling molecules in DEN-infected cells by western
blotting (Figure 4A). As expected, IRF3 phosphorylation and
expression of DEN viral protein NS3 and IFN-induced RIG-I
increased with DEN-2 infection. Furthermore, not only for MAVS
that is cleaved by DEN-2-induced caspases [21], the endogenous
MITA protein levels were also reduced in cells with DEN-2
infection through an infection time- and infection dose-dependent
manner (Figure 4A and 4B).
To ascertain whether cleavage of MITA discredits innate
immunity in response to DEN infection, we established stable
A549 cells overexpressing MITA or MPYS by lentiviral transduc-
tion. MITA is a DNA sensor and plasmid transfection activates its
signaling [24,27], however different from the transient transfec-
Figure 3. Mapping of the dengue protease cleavage site of MITA. (A) Schematic diagram and summarized properties of MITA constructs.
Constructs were N-terminal HA- and C-terminal V5-tagged and are numbered according to the amino acid residues. The potential cleavage site LRRG
in human MITA and the corresponding sequence IHCM in murine MPYS are indicated. (B) A549 cells were transfected with the full-length or deletion
constructs of MITA with or without the Flag-tagged dengue NS2B3. Transfectants were harvested for immunoblotting with antibodies indicated at
the right. The positions for full-length MITA are indicated by black arrows and the cleaved MITA by open arrows. (C) A549 cells were cotransfected
with Vip-Luc (0.2 mg), IRF3/pCR3.1 (0.3 mg), pRL-TK (0.1 mg), plus GFP control or the indicated MITA constructs (0.4 mg) for 24 h. The cells were
harvested and analyzed by dual-luciferase assay. The relative normalized luciferase activities are expressed as mean and SD (n=3per group), and
were compared by two-tailed Student’s t test. (D) Immunoblotting of A549 cells cotransfected with DEN-2 NS2B3 plus the indicated constructs of
MITA or MPYS for 24 h. (E) Dual-luciferase assay of A549 cells cotransfected with Vip-Luc (0.15 mg), IRF3/pCR3.1 (0.15 mg), pRL-TK (0.05 mg), plus the
wild-type or S135A-mutated dengue NS2B3 (0.35 mg) with MITA or MPYS (0.3 mg) for 24 h. GFP was used as the negative control. The cells were
harvested and analyzed by dual-luciferase assay. Data are expressed as mean and SD (n=3per group), and were compared by two-tailed Student’s t
test.
doi:10.1371/journal.ppat.1002780.g003
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basal IRF3 activation (Figure 4C). Upon stimulation with dsDNA,
we noted higher IRF3 phosphorylation triggered by poly(dA:dT)
in A549 cells expressing MITA or MPYS than the GFP control
(Figure S9). In response to DEN-2 infection, cells with MPYS
overexpression showed higher levels of IRF3 phosphorylation and
lower dengue viral NS3 protein expression than with the GFP
control (Figure 4C). However, in MITA-overexpressing cells,
MITA was cleaved, as indicated by the smaller protein fragments
recognized by anti-HA and anti-V5 antibodies (Figure 4C) and no
anti-DEN effect of MITA was noted because of similar levels of
dengue viral NS3 protein expression between MITA and control
GFP cells (Figure 4C). Furthermore, the cleaved MITA products,
HA-MITA-N or MITA-C-V5, had no effect on IRF3 phosphor-
ylation, no anti-DEN activity, and no further cleavage (Figure
S10). Consistent with the viral protein data detected by western
blotting, less infectious DEN-2 production was noted in MPYS-
expressing cells that had higher IFNb expression level (Figure 4D)
and stronger antiviral activity against IFN-sensitive dSinF-Luc/2A
(Figure 4E), as compared with the MITA-expressing cells
(Figure 4F).
Silencing MITA/MPYS attenuates host antiviral signaling
To further address the role of endogenous MITA/MPYS in
DEN infection, we knocked down the endogenous MITA
expression in A549 cells by lentivirus-delivered shRNA targeting
human MITA gene. A slight increase of DEN replication was
noted in iMITA cells, especially when a low MOI was used
(Figure 5A and Figure S11), probably reflecting that high MOI
of DEN infection blunts MITA efficiently and MITA knock-
down has little additional effect. We also noted that the levels of
IRF3 phosphorylation and IFN-induced RIG-I expression were
reduced in iMITA cells upon DEN-2 infection (Figure 5A),
supporting the notion that MITA plays a role in IFN signaling
during DEN infection. Consistent with the protein expression
data (Figure 5A), culture medium derived from DEN-2-infected
iMITA cells also exhibited lower antiviral activity against dSinF-
Luc/2A (Figure 5B) as compared to control knockdown cells. To
Figure 4. DEN replication is reduced by MPYS but not MITA. (A) A549 cells infected with DEN-2 (MOI 5) for various times were harvested for
western blot analysis. Immunoblotting was done with antibodies against pIRF3, IRF3, DEN NS3, RIG-I, MAVS, MITA, and actin as indicated. The band
density was quantified with ImageJ and the relative ratios of the indicated proteins are shown. (B) A549 cells infected with DEN-2 for 30 h with the
indicated MOI were harvested for western blot analysis. (C) Immunoblotting of A549 stable cell lines expressing HA-MITA-V5, HA-MPYS-V5, or HA-GFP
control infected with DEN-2 (MOI 10) for various times. The relative ratios of pIRF3/IRF3 and DEN-2 NS3/actin were analyzed as described in panel A.
The positions of full-length MITA and the cleaved MITA are indicated by black arrows and open arrows, respectively. (D) IFNb mRNA expression levels
in A549 cells with GFP, MITA or MPYS overexpression were quantified by RT-qPCR after DEN-2 infection for 24 h. (E) The conditioned medium
collected from DEN-2-infected cell lines expressing GFP, MITA or MPYS was analyzed for antiviral activity against IFN-sensitive dSinF-Luc/2A as
described in Materials and Methods. (F) DEN-2 virus production from A549 cells with GFP, MITA or MPYS overexpression was determined by plaque
forming assays at 24, 36, and 48 h post infection. The data in panels D, E, and F are mean and SD (n=3per group), and were compared by two-tailed
Student’s t test.
doi:10.1371/journal.ppat.1002780.g004
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anti-DEN host defense, we reduced the endogenous MPYS
expression of murine Hepa 1–6 cells that has been used for
DEN study [33] by shRNA targeting MPYS. DEN-2 viral
protein expression (Figure 5C) and viral progeny production
(Figure 5D) were enhanced in cells with reduced MPYS, further
supporting the antiviral role of MITA/MPYS and the need of
DEN to subvert it by protease degradation.
Cellular distribution of MITA/MPYS upon stimulation
MITA is known to be critical for intracellular DNA-mediated
IFN production but its role in dsRNA-triggered IFN production is
more controversial [27]. Since DEN is a RNA virus, we are
interested to know whether MITA/MPYS is activated in DEN-
infected cells. Because MITA forms cytoplasmic punctate struc-
tures during activation [30], we determined the cellular distribu-
tion of MITA and MYPS in DEN-infected cells. To avoid using
dsDNA plasmid transient transfection that activates MITA, we
used A549 cells stably expressing MITA or MPYS to examine the
cellular localization of MITA/MPYS. At the early time point of
DEN-2 infection, both MITA and MPYS showed homogenous
cytoplasmic distribution. However, at the later time point, MITA
was diminished likely through cleavage by DEN protease and then
degradation by cell machinery, while MPYS formed punctate
structures, suggesting that MPYS is activated by DEN-2 infection
(Figure 6A). We then established stable cells overexpressing the
wild-type NS2B3 plus MITA or MPYS by lentivirus transduction.
In the absence of stimulation, MITA/MPYS and dengue protease
co-existed in the same cells (Figure 6B) even though MITA is
cleavable by NS2B3, suggesting that certain stimulation is required
to facilitate this cleavage event. With dsDNA stimulation, MPYS
formed punctate structures but not MITA with NS2B3 expression
(Figure 6B), supporting the notion that MITA but not MPYS is
targeted by dengue protease.
MITA interacts with dengue protease, and dsDNA further
enhances this interaction
To further address the interplay of dengue protease with MITA
versus MPYS, cells were cotransfected with V5-tagged MITA or
MPYS plus the Flag-tagged WT or enzyme-dead (S135A) dengue
protease. Immunoprecipitation of NS2B3(S135A) with anti-Flag
antibody readily brought down MITA but not much of MPYS
(Figure 7A). Similar results were noted by immunoprecipitation of
MITA with anti-V5 antibody and then immunoblotting for
NS2B3 with anti-Flag antibody (Figure 7A). Interestingly, the
interaction between MITA and dengue NS2B3 was enhanced by
transfection with poly(dA:dT) but not much with poly(I:C)
(Figure 7B). To determine whether this interaction contributes to
the cleavage event, stable cells overexpressing the wild-type
NS2B3 plus MITA or MPYS were treated with poly(dA:dT) or
poly(I:C). A basal level of cleavage of MITA but not MPYS was
detected (Figure 7C, lanes 1 and 4), and this cleavage was further
enhanced by transfection with poly(dA:dT) but not with poly(I:C)
(Figure 7C).
A reduced level of the full-length endogenous MITA was noted
in cells with WT but not with enzyme-dead NS2B3 (S135A)
regardless of dsDNA stimulation (Figure 7D). We were not able to
detect the cleaved products of MITA protein probably due to
rapid degradation. The protein-protein interaction of endogenous
MITA and dengue protease could be demonstrated by immuno-
precipitation with anti-NS3 antibody and then western blotting
with anti-MITA antibody, especially in cells with the enzyme-dead
S135A NS2B3 (Figure 7E). Overall, we found that dengue
protease NS2B3 targets MITA, an important signaling molecule
Figure 5. Silencing MITA/MPYS attenuates host antiviral
signaling. (A) Human A549 cells stably expressing shRNA targeting
control LacZ or MITA were infected with DEN-2 (MOI 0.1 and 10) for
various times. Immunoblotting was performed with antibodies against
DEN NS3, pIRF3, IRF3, RIG-I, MAVS, MITA, and actin. (B) The conditioned
medium collected from mock or DEN-2-infected (MOI 10, 24 h p.i.) iLacZ
or iMITA cells was analyzed for antiviral activity against IFN-sensitive
dSinF-Luc/2A as described in Materials and Methods. Data are
expressed as mean and SD (n=3 per group), and were compared by
two-tailed Student’s t test. (C and D) Murine Hepa 1–6 cells stably
expressing shRNA targeting control LacZ or MPYS were infected with
DEN-2 (MOI 5) for 24 h. Cell lysates were analyzed by western blotting
with indicated antibodies (C) and culture supernatants were harvested
for DEN-2 virus titration by plaque forming assays (n=3) (D).
doi:10.1371/journal.ppat.1002780.g005
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downregulate the host defense mechanism.
Discussion
In this study, we found that MITA, a key adaptor molecule in
host innate immune response, is targeted by the DEN protease
NS2B3. MITA, also known as STING, MPYS and ERIS, is an
ER-localized transmembrane protein essential for IFN induction
triggered by DNA pathogens [27,34,35] and probably also by
some RNA viruses [23,24,27,36]. Targeting MITA during DEN
infection may result in reduced host defense against DEN, and
maybe also against DNA pathogens such as bacterial infection.
Even though concurrent bacteraemia in patients with dengue fever
is rare, some reports have implicated bacterial infection in severe
forms of dengue diseases. For example, secondary bacteraemia
was a contributor to death in 4 of the 9 adult patients who died of
dengue-related illness in Singapore [37]. A study in Taiwan
indicated that 5.5% of the patients with DHF/DSS had
concurrent bacteremia [38], and a study of DHF infants in India
showed 21% with bacterial co-infections [39]. Thus, our results
showing that DEN may modulate the innate immunity predispo-
sition to other infections provide a molecular explanation for the
mortality of nosocomial bacteraemia in dengue patients.
The protease activity of DEN NS3 depends on the association
with NS2B cofactor [40–42], and the viral NS2B3 protease cleaves
the viral polyprotein precursor at the junctions of NS2A/NS2B,
NS2B/NS3, NS3/NS4A, and NS4B/NS5 [40,43]. These cleavage
sites have the consensus sequence of two basic amino acids (KR,
RR, RK, and occasionally QR) at the 22 and 21 positions,
followed by a small amino acid (G, A, or S) at the +1 position
[40,42–44]. Previously, by using an IFNb-Luc reporter assay,
Figure 6. Cellular distribution patterns of MITA and MPYS upon stimulation. (A) A549 stable cell lines expressing HA-MITA-V5 or HA-MPYS-
V5 were infected with DEN-2 (MOI 20) for the indicated times and then fixed for IFA. Red, overexpressed MITA or MPYS stained with anti-V5 antibody;
green, DEN-2 NS3; blue, DAPI staining. IFA were analyzed by confocal laser scanning microscopy. (B) A549 stable cell lines overexpressing dengue
NS2B3(WT) plus MITA or MPYS were transfected with poly(dA:dT) (0.5 mg/ml) for 0, 2, and 8 h and analyzed by IFA as described in panel A.
doi:10.1371/journal.ppat.1002780.g006
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by DEN NS2B3 through a protease-dependent mechanism [22].
In this study, we further demonstrated that DEN protease reduced
IFN induction and IRF3 phosphorylation triggered by JEV
infection and by transfection with poly(I:C) and poly(dA:dT).
Furthermore, human MITA but not the murine homologue
MPYS was cleaved in cells expressing an enzyme-active but not
enzyme-dead NS2B3. From the sizes of the cleaved products,
LRRQ
96G, which matches the flaviviral protease consensus
sequences, was predicted to be the cleavage site of MITA by
DEN protease. Mutation of LRRG to the corresponding
sequence, IHCM found in murine MPYS that cannot be cleaved
by dengue protease, attenuated the cleavage pattern of MITA,
suggesting that MITA is a substrate of dengue NS2B3.
However, we cannot exclude the possibility that MITA is
cleaved by a yet-to-be identified cellular protease that depends on
the activity of dengue NS2B3. The cleavage sites for JEV and
DEN proteases share the same consensus sequences; but different
from the data for DEN infection and DEN protease, JEV infection
and JEV NS2B3 expression failed to trigger cleavage of MITA,
suggesting that other factors, besides the presence of flaviviral
protease, also govern this MITA cleavage event. Furthermore, this
DEN protease-mediated cleavage of MITA could be enhanced by
dsDNA stimulation, suggesting that some dsDNA-induced factor(s)
also participate in this cleavage event. So far we could conclude
that MITA, but not MPYS, is specifically cleaved by either DEN
protease itself or by host protease(s) depending on the activity of
DEN protease. This different response between human MITA and
murine MPYS provides a potential clue to improve the animal
models for DEN pathogenesis study.
As outlined in Figure 8, in unstimulated cells, MITA mainly
localizes to the endoplasmic reticulum (ER) [24,25,30]. Following
stimulation, MITA translocates from the ER to the Golgi and
finally assembles with TBK1 in punctate membrane structures,
which is required for activation of downstream signals [30].
Dengue NS3 protease also targets to ER by interacting with its
cofactor NS2B [45]. Here, we found that MITA and dengue
NS2B3 physically interact with each other, and this interaction
could be further enhanced by stimulation with poly(dA:dT). The
cleavage of MITA by NS2B3 could also be enhanced by
poly(dA:dT), suggesting that NS2B3 would encounter the
dsDNA-driven trafficking MITA [30] and execute the cleavage.
The cleavage decreasing the function of MITA is further
supported by loss of punctate structures with MITA triggered by
dsDNA stimulation in cells with dengue NS2B3.
MITA is known to be critical for intracellular DNA-mediated
IFN production but its role in RNA-triggered IFN production is
not so clear [27]. However, MITA is required for IFN induction
triggered by RNA viruses such as SeV [23] and VSV [27]. VSV
[23,24,27] and Newcastle disease virus [25] are also sensitive to
the antiviral activity mediated by MITA both in vitro and in vivo.
Thus, MITA is likely not only a DNA sensor, but also involved in
RNA viruses signaling. Consistent with the previous study [30],
poly(I:C) did not trigger MPYS activation marker, cytoplasmic
punctate structures (Figure S12), however DEN-2 infection
induced MPYS punctate structures. These results suggest that
poly(I:C) transfection may not completely recapitulate the events
occurring during DEN infection. Several possibilities may
contribute to this discrepancy, for example viral RNA may possess
of property more than poly(I:C) and/or the host, both genomic
Figure 7. Dengue protease NS2B3 interacts with MITA. (A) Immunoprecipitation and western blot analysis (IP-WB) of 293T/17 cells
cotransfected with dengue NS2B3 (WT or S135A-mutated) plus MITA or MPYS for 18 h with the indicated antibodies. (B) IP-WB analysis of 293T/17
cells cotransfected with S135A-mutated NS2B3 and MITA for 48 h, then the cells were treated with different doses of poly(dA:dT) or poly(I:C) as
indicated for 18 h. (C) Western blot analysis of A549 stable cell lines overexpressing dengue NS2B3(WT) plus MITA or MPYS treated with poly(dA:dT)
or poly(I:C) (0, 0.5, and 1 mg/ml) for 24 h with antibody against V5-tag. Black arrow, full-length MITA; open arrow, cleaved MITA. A549 stable cell lines
overexpressing dengue NS2B3 (WT or S135A) were stimulated with poly(dA:dT) (0.5 mg/ml) for 24 h and then analyzed by western blotting (D) and by
IP-WB (E) analysis with the indicated antibodies. Black arrow indicates the full-length endogenous MITA.
doi:10.1371/journal.ppat.1002780.g007
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activate the MITA/MPYS signaling pathway.
DEN is a weak inducer of type I IFN, and DEN-infected human
dendritic cells showed a reduced type I IFN response to infection
with several viruses and to stimulation with poly(I:C) [11,20,22].
Several molecules of the IFN-inducing pathway are targeted by
members of the Flaviviridae family. MAVS is cleaved by HCV
NS3/4A protease [14,18] and by caspase-1 and caspase-3 induced
by DEN infection [21]. A sequence homology between flaviviral
NS4B and MITA (a.a. 125–222) has been reported, and the IFN
induction ability of MITA was downregulated by yellow fever
virus NS4B [27]. DEN-encoded NS2B3 protease apparently also
targets the human MITA. DEN replication levels were reduced in
cells expressing the murine homologue of MITA, MPYS, which
cannot be cleaved by dengue protease, suggesting that DEN
replication benefits from MITA cleavage with dengue NS2B3.
Because dengue protease is essential for DEN replication, it has
been extensively investigated as an antiviral target. Whether drugs
that block DEN protease can affect DEN replication and rescue
the MITA-mediated innate immune response and influence DEN
pathogenesis is of great interest.
Materials and Methods
Viruses, cells, and chemicals
DEN and JEV propagation and titration were as described
previously [21,46]. IFN-sensitive dSinF-Luc/2A sindbis virus [32]
and vesicular stomatitus virus (VSV) were amplified in Vero cells
as described [47]. IFNa-2a (Roferon-A) was from Roche. 293T/
17 cells (ATCC, CRL-11268) and murine hepatoma Hepa 1–6
cells (ATCC CRL-1830) were cultured in DMEM medium
supplemented with 10% FBS. A549, a human lung carcinoma
cell line, was cultured in F-12 medium supplemented with 10%
FBS. African green monkey kidney Vero cells were cultured in
MEM supplemented with 10% FBS and 2 mM L-glutamine.
PolyJet transfection reagent (SignaGen Laboratories) and Lipo-
fectamine 2000 (Invitrogen) were used according to the manufac-
turer’s instructions. Poly(dA:dT) naked and Poly(I:C) LMW were
obtained from InvivoGen and delivered into cells by transfection
with Lipofectamine 2000.
Plasmids
pRK-HA-MITA and pRK-Flag-MITA were kindly provided
by Dr. Hong-Bing Shu. The cDNA of MPYS was cloned by PCR
with the primers: XhoI-mMITA(1–22): 59-ACCGctcgagATGC-
CATACTCCAACCTGCATC-39 and mMITA(1136–1114)-
XbaI: 59-CTAGtctagaCAGATGAGGTCAGTGCGGAGTGG-
39, and the sequences were identical to that of murine MPYS
(GenBank accession no. NM_028261). To add tags to both ends of
MITA, HA-MITA was subcloned into the V5-His/pcDNA3.1
vector (Invitrogen). Primers for deletions and mutations of MITA
or MPYS are listed in Figure S7. The pTY lentiviral expression
system was obtained from Dr. Lung-Ji Chang [48–50]. The
lentivirus vector carrying the shRNA targeting human MITA (59-
CATGGTCATATTACATCGGAT-39, TRCN0000160281),
murine MPYS (59-AGAGGTCACCGCTCCAAATAT-39,
TRCN0000346319) or LacZ (59-TGTTCGCATTATCCGAAC-
CAT-39, TRCN0000072223), and the lentiviral vectors for cDNA
overexpression, pLKO.1_AS3w.puro and pLKO.1_AS3w.bsd,
were from the National RNAi Core Facility, Taiwan. Lentivirus
was prepared following the protocol of the National RNAi Core
Facility (Academia Sinica, Taiwan). The pCR3.1 vectors express-
ing DEN-2 NS2B3 and its S135A mutant have been described
previously [46]. The cDNAs of NS2B3 and NS2B3(S135A) were
subcloned to pTY vector for lentivirus production.
Reporter assay
To assess the effect of DEN protease on MITA-mediated gene
induction, A549 cells were cotransfected with viperin promoter-
driven reporter Vip-Luc [31] (0.15 mg), IRF3/pCR3.1 [11]
(0.15 mg), MITA/pcDNA3.1 (0.3 mg), internal control pRL-TK
(Promega) (0.05 mg), and various doses of NS2B3/pCR3.1 (WT or
S135A-mutant) (0.3, 0.45, and 0.6 mg) for 24 h. GFP/pCR3.1 was
used as plasmid control. The cell lysates were harvested and
Figure 8. DEN antagonizes MITA-mediated antiviral signaling. Activated MITA translocates from ER to associate with Sec5 translocon
complex, and then reaches the cytoplasmic punctate structures to assemble with TBK1. This activation process leads to phosphorylation and
translocation of IRF3, and then induces antiviral IFN production. DEN-encoded protease NS2B3 targets human MITA at LRRQ
96G but not the murine
homologue MPYS for cleavage, thus subverts the MITA-triggered antiviral signaling.
doi:10.1371/journal.ppat.1002780.g008
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luciferase activity (Vip-Luc) was normalized to that of renilla
luciferase (pRL-TK) and the relative luciferase activities are
shown.
RT-qPCR analysis
Total RNA was prepared with an RNeasy RNA Mini Kit
(Qiagen) and the cDNA was reverse transcribed from 1 mg of total
RNA with random hexamer primer using a ThermoScript RT kit
(Invitrogen). qPCR was then carried out using the specific primer
sets for IFNb (59-CACGACAGCTCTTTCCATGA-39 and 59-
AGCCAGTGCTCGATGAATCT-39) and actin (59-TCCTG-
TGGCATCCACGAAACT-39 and 59-GAAGCATTTGCGGT-
GGACGAT-39) with the LightCycler FastStart DNA Master
PLUS SYBR Green I kit (Roche), according to the manufacturer’s
recommendations. The level of IFNb was normalized to that of
actin based on the second derivative maximum method (Roche).
Melting curves were used to verify the specificity of PCR products.
Antiviral activity of conditioned medium
Conditioned medium was harvested and two-fold serial diluted
with fresh medium. 1610
5 Vero cells were cultured with the
diluted medium for 18 h in a 24-well plate and then infected with
dSinF-Luc/2A sindbis virus (500 pfu/well). The cell lysates were
harvested for luciferase activity assay (Promega) at 24 h p.i. The
conditioned medium collected from DEN-2-infected cells was UV-
inactivated [11] before serial dilution.
Immunofluorescence assay
For IRF3 nuclear translocation assay, cells were fixed with 4%
paraformaldehyde in PBS and then permeabilized by 0.5%
TritonX-100. After blocking with skim milk in PBS with 0.1%
Tween-20 (PBS-T), antibodies against IRF3 (1:200; Santa Cruz
Biotechnology) were added overnight. Biotin-conjugated goat
anti-rabbit antibody and Cy3-conjugated streptavidin (1:1000;
Jackson ImmunoResearch) was added sequentially on the next
day for 1 h at room temperature. Primary antibodies against JEV
and DEN NS1 and NS3 (1:1000) and goat anti-mouse Alexa
Fluor-488-conjugated secondary antibody (1:1000; Molecular
Probes) were used for 1 h at room temperature. Cells were
examined and photographed by use of an inverted fluorescent
microscope. For the samples examined under a fluorescence laser
scanning confocal microscope (FV1000, Olympus), cells were
seeded in m-Slides chamber slides (ibidi) overnight before
treatments.
Western blot analysis
Cells were lysed with RIPA buffer (10 mM Tris, pH 7.5, 5 mM
EDTA, 150 mM NaCl, 0.1% SDS, 1% TritonX-100, 1% sodium
deoxycholate) containing a cocktail of protease and phosphatase
inhibitors (Roche). Protein samples were separated by SDS-PAGE
and transferred to a nitrocellulose membrane (Hybond-C Super,
Amersham). The nonspecific antibody binding sites were blocked
with skim milk in PBS-T and then reacted with the primary
antibodies: anti-phospho-IRF3 (S396) (1:1000; Cell Signaling),
anti-IRF3 (1:1000; Santa Cruz Biotechnology), anti-actin
(1:10000; Chemicon), anti-TMEM173 (1:2000; Novus), anti-
RIG-I (1:1000; Cell Signaling), anti-MAVS (1:1,000; Axxora),
anti-HA (1:2000; Covance), anti-V5 (1:5000; Sigma-Aldrich), and
anti-Flag M2 (1:5000; Sigma-Aldrich). Blots were treated with
horseradish peroxidase-conjugated secondary antibody (1:2500;
Jackson ImmunoResearch), and signals were detected by en-
hanced chemiluminescence (ECL, Pierce). For native PAGE,
sample preparation and electrophoresis in the presence of
deoxycholate (DOC) were performed as previously described
[11]. Briefly, cells were lyzed in protein lysis buffer (50 mM Tris-
HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% NP-40)
containing a cocktail of protease inhibitors. Cell lysates (10 mg)
in native sample buffer (62.5 mM Tris–HCl [pH 6.8], 15%
glycerol, and 1% DOC) were separated by 7.5% PAGE without
SDS for 60 min at 25 mA. The electrophoresis buffer contained
25 mM Tris-HCl and 192 mM glycine (pH 8.4) with and without
1% DOC in the cathode and anode chambers, respectively.
Co-immunoprecipitation
Cells were lysed with protein lysis buffer containing a cocktail of
protease and phosphatase inhibitors (Roche). Cell lysates were
immunoprecipitated with mouse anti-V5 antibodies (1:1000;
Sigma-Aldrich) or mouse anti-Flag beads (Sigma-Aldrich) over-
night at 4uC. The immunocomplex was captured by use of protein
G-coated beads (GE Healthcare) at 4uC for 2 h, then precipitates
were washed with protein lysis buffer and resuspended in sample
buffer with 2-mercaptoethanol. For immunoprecipitation of
endogenous MITA, cells were lysed with protein lysis buffer plus
1% TritonX-100. The immunoprecipitated samples were exam-
ined by Western blot analysis.
Statistical analysis
Data are presented as mean 6 standard deviation (SD). The
results of the indicated groups were compared by two-tailed
Student’s t test.
Supporting Information
Figure S1 Dengue NS2B3 suppresses JEV-induced IRF3
phosphorylation. A549 cells stably transduced with control
GFP or DEN-2 NS2B3 were mock-infected (lanes 1–6) or infected
with JEV (MOI 5, lanes 7–12) for 16, 24, and 36 h.
Immunoblotting was performed with antibodies against pIRF3,
IRF3, JEV NS1, GFP, DEN NS3, and actin as indicated.
(TIFF)
Figure S2 JEV replication level was similar between
A549 cells stably expressing GFP or DNS2B3. Culture
supernatants of JEV-infected (MOI 5 for 24 h) A549 stable cells
with GFP or dengue NS2B3 (WT or S135A) were analyzed by
plaque forming assays for JEV titration. Data are expressed as
mean and SD (n=3per group), and were compared by two-tailed
Student’s t test. NS: not significant.
(TIFF)
Figure S3 Dengue protease downregulates the IFNb
promoter activation triggered by MITA. A549 cells were
cotransfected with p125-Luc (0.15 mg), IRF-3/pCR3.1 (0.15 mg),
pRL-TK (0.05 mg), DNS2B3 (WT or S135A, 0.6 mg) and MITA
(0.3 mg) for 24 h. GFP transfection was used as a negative control.
The cell lysates were harvested and analyzed by dual-luciferase
assay as described in Figure 2.
(TIFF)
Figure S4 Vip-Luc and p125-Luc triggered by TBK1
were not affected by dengue protease. A549 cells were
cotransfected with either reporter (Vip-Luc or p125-Luc; 0.15 mg),
IRF-3/pCR3.1 (0.15 mg), pRL-TK (0.05 mg), DNS2B3 (0.35 mg)
and TBK1 (0.3 mg) for 24 h. GFP transfection was used as a
negative control. The cell lysates were harvested and analyzed by
dual-luciferase assay as described in Figure 2.
(TIFF)
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antiviral activity against VSV. Vero cells were pretreated
with 2-fold serial diluted medium derived from A549 cells
cotransfected with DNS2B3 (WT or S135A) plus MITA or GFP
control as indicated. The conditioned Vero cells were infected
with VSV (25 pfu/well) for 2 days, and adherent cells were stained
by crystal violet.
(TIFF)
Figure S6 DEN-2 infection benefits replication of IFN-
sensitive sindbis virus. (A) Vero cells were treated with
various doses of IFNa-2a for 18 h and then infected with
recombinant sindbis virus dSinF-Luc/2A for 24 h. Cell lysates
were harvested for luciferase activity assay. (B) A549 cells were
infected with DEN-2 (MOI 5) for 10 h and then superinfected
with dSinF-Luc/2A (MOI 10) for 20 h. Cell lysates were harvested
for luciferase activity assay. Data are expressed as mean and SD
(n=3 per group), and were compared by two-tailed Student’s t
test.
(TIFF)
Figure S7 Mutation analysis of MITA. (A) Schematic
diagram of MITA/MPYS constructs with mutation sequences.
(B) Immunoblotting analysis of A549 cells cotransfected with
dengue NS2B3 plus the indicated MITA–mutation constructs. (C)
Dual-luciferase assay of A549 cells cotransfected with Vip-Luc,
IRF3/pCR3.1, pRL-TK, and the indicated MITA constructs for
24 h as described in Figure 2. (D) Sequences of primers used for
MITA/MPYS mutagenesis.
(TIFF)
Figure S8 DEN protease interacts with MITA but not
much with MPYS. IP-western analysis of A549 cells cotrans-
fected with S135A-mutated dengue NS2B3 plus V5-tagged MITA
(WT or IHCM-mutant) or MPYS (WT or LRRG-mutant) for
24 h with the indicated antibodies.
(TIFF)
Figure S9 Activation of IRF3 in stable cell lines express-
ing MITA or MPYS upon dsDNA stimulation. Western blot
analysis of pIRF3, IRF3, and actin in A549 stable cell lines
overexpressing GFP, MITA, or MPYS transfected with poly(-
dA:dT) (0.5 or 1 mg) at 6 h post transfection. The band density was
quantified with ImageJ and the relative ratios of pIRF3 to IRF3
are shown.
(TIFF)
Figure S10 DEN infection of stable cell lines overex-
pressing cleaved-MITA mimics. A549 stably overexpressing
GFP, MITA-N, or MITA-C were infected with DEN-2 (MOI 10)
and harvested at the indicated time points post infection. Samples
were analyzed by immunoblotting analysis with specific antibodies
as indicated.
(TIFF)
Figure S11 DEN-2 viral production levels in A549 cells
with MITA knockdown. A549 cells stably expressing shRNA
targeting LacZ or MITA were infected with DEN-2 (MOI 0.1 or
10). The culture supernatants were collected for DEN-2 titration
at 42 h p.i. by plaque forming assays.
(TIFF)
Figure S12 MPYS forms cytoplasmic punctate struc-
tures with poly(dA:dT) but not poly(I:C) stimulation.
A549 cells with MPYS stable expression were treated with
poly(I:C) or poly(dA:dT) (0.5 mg/ml) for 4 h. The cellular
distribution of MPYS was revealed by antibody against V5-tag
(red). Nuclei stained with DAPI (blue).
(TIFF)
Table S1 Reduction of IRF3 nucleus translocation by
dengue protease. The raw data collected for calculating the
nucleus translocation rate shown in Figure 1B.
(TIFF)
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